(Q35925607)

11 August 2017

1 reference

title

Non-viral delivery of ribozymes for cancer gene therapy (English)

1 reference

11 August 2017

0 references

0 references

1 reference

Mohammed Kashani-Sabet

series ordinal

1

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

Expert Opinion on Biological Therapy

11 August 2017

published in

1 reference

11 August 2017

volume

4

1 reference

11 August 2017

issue

11

1 reference

11 August 2017

page(s)

1749-1755

1 reference

The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

The intervening sequence RNA of Tetrahymena is an enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

Ribozymes in the age of molecular therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

Dissecting the metastatic cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

Dissemination and growth of cancer cells in metastatic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

Nuclease-resistant synthetic ribozymes: developing a new class of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

Synthesis, deprotection, analysis and purification of RNA and ribozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

Acute toxicology and pharmacokinetic assessment of a ribozyme (ANGIOZYME) targeting vascular endothelial growth factor receptor mRNA in the cynomolgus monkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

Delivery of unmodified bioactive ribozymes by an RNA-stabilizing polyethylenimine (LMW-PEI) efficiently down-regulates gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

Adenoviruses as gene-delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

Non-replicating Epstein-Barr virus-based plasmids extend gene expression and can improve gene therapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

Identification of gene function and functional pathways by systemic plasmid-based ribozyme targeting in adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

NF-kappa B in the vascular progression of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

Identification of a functional NF-kappa B site in the platelet endothelial cell adhesion molecule-1 promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

NF-kappa B regulates transcription of the mouse telomerase catalytic subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

Abrogation of lung metastasis of human fibrosarcoma cells by ribozyme-mediated suppression of integrin alpha6 subunit expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

Deregulation of NF-kappaB and its upstream kinases in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.4.11.1749

10.1517/14712598.4.11.1749

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference